DekaBank Deutsche Girozentrale Has $126.85 Million Stock Position in CVS Health Corporation (NYSE:CVS)

DekaBank Deutsche Girozentrale raised its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,901,908 shares of the pharmacy operator's stock after purchasing an additional 43,352 shares during the period. DekaBank Deutsche Girozentrale owned about 0.15% of CVS Health worth $126,847,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Hopwood Financial Services Inc. purchased a new stake in CVS Health during the 4th quarter valued at about $29,000. McIlrath & Eck LLC raised its holdings in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Park Square Financial Group LLC acquired a new position in shares of CVS Health during the fourth quarter valued at approximately $43,000. PARK CIRCLE Co increased its holdings in shares of CVS Health by 42.9% in the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after purchasing an additional 300 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL increased its holdings in shares of CVS Health by 77.2% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock valued at $46,000 after purchasing an additional 446 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

CVS has been the subject of several research analyst reports. UBS Group raised their price target on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price objective (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $75.06.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is owned by corporate insiders.

CVS Health Price Performance

Shares of CVS traded down $1.09 during mid-day trading on Friday, hitting $64.53. 2,312,076 shares of the company traded hands, compared to its average volume of 10,764,601. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The business has a 50-day moving average of $65.10 and a 200 day moving average of $62.08. The stock has a market capitalization of $81.63 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 0.95 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period last year, the firm earned $1.31 earnings per share. The business's revenue for the quarter was up 7.0% on a year-over-year basis. As a group, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.12%. CVS Health's dividend payout ratio is presently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.